EUVIMEDEUVIMED entdecken
Open Access

Synergistic antimicrobial combination of third-generation cephalosporins and polymyxin B against carbapenem-polymyxin-resistant Klebsiella pneumoniae: an in vitro and in vivo analysis

Mariana Carvalho Sturaro, Nathalia da Silva Damaceno, Izadora Dillis Faccin, Osmar Nascimento Silva, Thiago Mendonça de Aquino, Nathalia Monteiro Lins Freire, Marcone Gomes Dos Santos Alcântara, Kadja Luana Chagas Monteiro, Luana Rossato, Gleyce Hellen de Almeida de Souza, Simone Simionatto iD

Antimicrobial Agents and Chemotherapy · 2024

DOI: 10.1128/aac.00930-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Mariana Carvalho Sturaro und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Pesquisa em Ciências da Saúde, Universidade Federal da Grande Dourados, Dourados, Brazil. Hauptthemen laut MEDLINE: Polymyxin B, Klebsiella pneumoniae, Anti-Bacterial Agents, Drug Synergism. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibiotic combination therapy is a promising approach to address the urgent need for novel treatment options for infections caused by carbapenem-polymyxin-resistant Klebsiella pneumoniae (CPR-Kp). The present study aimed to investigate the synergistic potential of four cephalosporins in combination with polymyxin B (PMB). A checkerboard assay was performed to evaluate the synergistic effects of cephalexin (CLX), cefixime, cefotaxime (CTX), and cefmenoxime (CMX) in combination with PMB. Subsequently, experiments evaluating the use of CTX or CMX in combination with PMB (CTX-PMB or CMX-PMB, respectively), including growth curve and SynergyFinder analysis, antibiofilm activity assays, cell membrane integrity assays, and scanning electron microscopy, were performed. Safety assessments were also conducted, including hemolysis and toxicity evaluations, using Caenorhabditis elegans . Furthermore, an in vivo model in C. elegans was adopted to assess the treatment efficacy against CPR-Kp infections. CTX-PMB and CMX-PMB exhibited low fractional inhibitory concentration indexes ranging from 0.19 to 0.50 and from 0.25 to 1.5, respectively, and zero interaction potency scores of 37.484 and 15.076, respectively. The two combinations significantly reduced growth and biofilm formation in CPR-Kp. Neither CTX-PMB nor CMX-PMB compromised bacterial cell integrity. Safety assessments revealed a low hemolysis percentage and high survival rates in the C. elegans toxicity evaluations. The in vivo model revealed that the CTX-PMB and CMX-PMB treatments improved the survival rates of C. elegans . The synergistic effects of the CTX-PMB and CMX-PMB combinations, both in vitro and in vivo , indicate that these antibiotic pairings could represent effective therapeutic options for infections caused by CPR-Kp.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polymyxin BKlebsiella pneumoniaeAnti-Bacterial AgentsDrug SynergismMicrobial Sensitivity TestsCaenorhabditis elegansBiofilmsCephalosporinsAnimalsCarbapenemsKlebsiella InfectionsDrug Resistance, Multiple, BacterialDrug Therapy, Combination

Stichwörter der Autor:innen

Caenorhabditis elegansKlebsiella pneumoniaeantimicrobial resistancecephalosporinscombination therapy

Substanzen

Polymyxin BAnti-Bacterial AgentsCephalosporinsCarbapenems

Autor:innen und Institutionen

  • Laboratório de Pesquisa em Ciências da Saúde, Universidade Federal da Grande Dourados, Dourados, Brazil.
  • Universidade Católica de Brasília, Brasilia, Brazil.
  • Laboratório de Síntese e Pesquisa em Química Medicinal, Instituto de Química e Biotecnologia, Universidade Federal de Alagoas, Maceió, Brazil.

ORCID-Profile: Simone Simionatto

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
  • Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Zitieren

APA

Sturaro, M. C., Damaceno, N. S., Faccin, I. D., Silva, O. N., de Aquino, T. M., Freire, N. M. L., Alcântara, M. G. S., Monteiro, K. L. C., Rossato, L., de Souza, G. H. A., & Simionatto, S. (2024). Synergistic antimicrobial combination of third-generation cephalosporins and polymyxin B against carbapenem-polymyxin-resistant Klebsiella pneumoniae: an in vitro and in vivo analysis. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00930-24

Vancouver

Sturaro MC, Damaceno NS, Faccin ID, Silva ON, de Aquino TM, Freire NML, et al. Synergistic antimicrobial combination of third-generation cephalosporins and polymyxin B against carbapenem-polymyxin-resistant Klebsiella pneumoniae: an in vitro and in vivo analysis. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.00930-24

BibTeX
@article{Sturaro2024,
  author = {Sturaro, Mariana Carvalho and Damaceno, Nathalia da Silva and Faccin, Izadora Dillis and Silva, Osmar Nascimento and de Aquino, Thiago Mendonça and Freire, Nathalia Monteiro Lins and Alcântara, Marcone Gomes Dos Santos and Monteiro, Kadja Luana Chagas and Rossato, Luana and de Souza, Gleyce Hellen de Almeida and Simionatto, Simone},
  title = {Synergistic antimicrobial combination of third-generation cephalosporins and polymyxin B against carbapenem-polymyxin-resistant Klebsiella pneumoniae: an in vitro and in vivo analysis},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  doi = {10.1128/aac.00930-24}
}
Kostenlos starten →